Global Radioimmunoassay Market, By Product Type (Reagents and Kits, Analyzers), Application (Scientific Research, Clinical Diagnostic), End User (Hospitals, Pharmaceutical and Biotechnology Industry, Academic Institutions, Clinical Diagnostic Laboratories, Contract Research Organizations (CRO)), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Radioimmunoassay market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 570.18 million by 2028 and will grow at a CAGR of 4.10% in the above mentioned forecast period.
Radioimmunoassay is a type of a technique which is most often used in-vitro assay to determine the concentration of antigens in blood. The principle on which radioimmunoassay is based is the competitive binding assay. In this technique, antigen and antibody bind to one another and the amount of bound antigen is considered using radioimmunoassay. This process is hypersensitive in nature and can calculate even the least amount of hormone or drug level with the help of antibodies.
The increasing incidence of various infectious diseases and cancer is amongst the important factors intensifying the growth and demand of radioimmunoassay market. In addition, the rapid advancements in medical research, clinical trials as well as the increasing geriatric population with cancer indication are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the growing need for quality and error-free results to make sure patient satisfaction has resulted in research labs and diagnostic centers to decide on high-throughput and automated procedures which are also enhancing the growth of the market. Likewise, the increasing adoption of technologically advanced devices along with the high adoption of innovative products is also lifting the market growth in the above mentioned forecast period. Also, the growing demand for healthcare automation and is also one of the significant factors fueling the growth of the radioimmunoassay market.
The increased usage in pharmaceutical industries and research as well as increasing need for quality and error-free diagnosis and technological advancements will further accelerate the expansion of the radioimmunoassay market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high cost of equipment required for procedures and various hazardous radioactive materials in the assay will curb the growth of the radioimmunoassay market, whereas the high costs coupled with the usage of radioimmunoassay and the strict regulatory restriction have the potential to challenge the growth of the radioimmunoassay market.
This radioimmunoassay market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on radioimmunoassay market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Radioimmunoassay Market Scope and Market Size
Radioimmunoassay market is segmented on the basis of product type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product type, the radioimmunoassay market is segmented into reagents and kits and analyzers.
- On the basis of application, the radioimmunoassay market is segmented into scientific research and clinical diagnostic.
- The end user segment of radioimmunoassay market is segmented into hospitals, pharmaceutical and biotechnology industry, academic institutions, clinical diagnostic laboratories and contract research organizations (CRO).
Radioimmunoassay Market Country Level Analysis
Radioimmunoassay market is analyzed and market size insights and trends are provided by country, product type, application and end user as referenced above.
The countries covered in the radioimmunoassay market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the radioimmunoassay market owing to the high adoption of technologically advanced devices, high infection rates, rising awareness amongst the people, better medical facilities and increasing adoption of innovative products within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the strong presence of large number of population suffering from chronic diseases and rising healthcare research activities within this particular region.
The country section of the radioimmunoassay market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Radioimmunoassay market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for radioimmunoassay market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the radioimmunoassay market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Radioimmunoassay Market Share Analysis
Radioimmunoassay market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to radioimmunoassay market.
The major players covered in the radioimmunoassay market report are MP BIOMEDICALS, Berthold Technologies GmbH & Co. KG, Abbexa, Beckman Coulter, Inc, DRG International, Inc., Cisbio, DiaSorin S.p.A., MyBioSource, Inc., Merck KGaA, DIAsource ImmunoAssays SA, PerkinElmer Inc., Tecan Trading AG, Denator, Abbott, ZAGENO Inc, Labcompare, Marin Biologic Laboratories, Inc., Creative Diagnostics, STRATEC SE, and Demeditec Diagnostics GmbH among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Radioimmunoassay Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.